Michael E. Abram

Michael E. Abram

AstraZeneca, Sweden - Södertälje / Sweden
Others
AD Scientific Index ID: 4401055
-
person_outline Michael E. Abram's MOST POPULAR ARTICLES
1-) Nirsevimab for prevention of RSV in healthy late-preterm and term infants N Engl J Med 386 (9), 837-846, 2022
2-) Nature, position, and frequency of mutations made in a single cycle of HIV-1 replication J Virol 84 (19), 9864-9878, 2010
3-) The SARS-CoV-2 monoclonal antibody combination, AZD7442, is protective in non-human primates and has an extended half-life in humans Sci Trans Med 14 (635), eabl8124, 2022
4-) Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48-week results from a single … J Acquir Immune Defic Syndr 71 (5), 530-7, 2016
5-) Switching to tenofovir alafenamide, coformulated with elvitegravir, cobicistat, and emtricitabine, in HIV-infected patients with renal impairment: 48-week results from a single …A Pozniak, JR Arribas, J Gathe, SK Gupta, FA Post, M Bloch, ...J Acquir Immune Defic Syndr 71 (5), 530-7, 20162162016